Word

V

Status

Dead

Status Code

710

Status Date

Friday, November 17, 2023

Serial Number

86698241

Registration Number

5193786

Registration Date

Tuesday, May 2, 2017

Mark Type

3000

Filing Date

Monday, July 20, 2015

Published for Opposition

Tuesday, February 14, 2017

Cancellation Date

Friday, November 17, 2023

Trademark Owner History

Vectura Limited - Original Registrant

Classifications

41 Education services, namely, providing of training, lectures and symposia all relating to pharmaceuticals or drug delivery devices

5 Pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system; pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical and veterinary preparations for the alleviation or prevention of pain or inflammation; inhalers filled with powders for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical preparations, namely, powders for asthma inhalers; pharmaceutical preparations, namely, powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; medicaments for inhalation therapy; pharmaceutical preparations, namely, pulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticals, namely, drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals; medicaments for the treatment of erectile dysfunction; medicaments for the treatment of chronic obstructive pulmonary disease; medicaments for the treatment of premature ejaculation; medicaments for the treatment of cystic fibrosis; medicaments for the treatment of female sexual dysfunction; medicaments for the treatment of migraines; medicaments for the treatment of asthma

16 Printed matter, namely, books, magazines, journals, newsletters in the field of pharmaceutical preparations and medical apparatus and drug delivery devices; printed photographs; stationery; plastic materials for packaging, namely, bags and bubble packs; all the aforesaid being goods relating to pharmaceuticals or drug delivery devices

10 Inhalers for medical or therapeutic purposes and parts and fittings therefor; inhaler devices sold empty for medical or therapeutic purposes and parts and fittings therefor; aerosol dispensers for medical or therapeutic purposes and parts and fittings therefor

42 Scientific research and technological services, namely, research, design, analysis, and testing, in the field of medicine, pharmaceuticals and drug delivery systems and drug delivery devices; research services in the fields of medicine and drug delivery devices systems and devices; pharmaceutical research services; pharmaceutical products development services; device and product safety testing services; preparation and formulation of pharmaceuticals, namely, consulting services in the field of pharmaceutical formulation, development of medical applications for drugs and pharmaceutical formulations, drug design, drug formulation, pharmaceutical formulation, and development of pharmaceutical formulations

The mark consists of a stylized letter "V" in the center of a circle with a dark background. The points of the "V" break the border of the circle. There is a shadow underneath the bottom of the circle and along the upper portion of the "V".
VECTURA
Color is not claimed as a feature of the mark.

Trademark Events

Nov 17, 2023

Cancelled Sec. 8 (6-Yr)

May 2, 2022

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

May 2, 2017

Registered-Principal Register

Feb 14, 2017

Official Gazette Publication Confirmation E-Mailed

Feb 14, 2017

Published For Opposition

Jan 25, 2017

Notification Of Notice Of Publication E-Mailed

Jan 9, 2017

Law Office Publication Review Completed

Jan 4, 2017

Approved For Pub - Principal Register

Jan 3, 2017

Examiner's Amendment Entered

Jan 3, 2017

Notification Of Examiners Amendment E-Mailed

Jan 3, 2017

Examiners Amendment E-Mailed

Jan 3, 2017

Examiners Amendment -Written

May 25, 2016

Notification Of Non-Final Action E-Mailed

May 25, 2016

Non-Final Action E-Mailed

May 25, 2016

Non-Final Action Written

May 4, 2016

Teas/Email Correspondence Entered

May 4, 2016

Correspondence Received In Law Office

May 2, 2016

Teas Response To Office Action Received

Nov 5, 2015

Notification Of Non-Final Action E-Mailed

Nov 5, 2015

Non-Final Action E-Mailed

Nov 5, 2015

Non-Final Action Written

Oct 29, 2015

Assigned To Examiner

Oct 19, 2015

Preliminary/Voluntary Amendment - Entered

Oct 9, 2015

Assigned To Lie

Sep 21, 2015

Teas Voluntary Amendment Received

Jul 25, 2015

Notice Of Design Search Code E-Mailed

Jul 24, 2015

New Application Office Supplied Data Entered

Jul 23, 2015

New Application Entered